NPM1 and acute myeloid leukemia: To test the hypothesis that T-cell mediated immune response contributes to disease control in patients with NPM1 mutation, we compared the distribution of HLA class I allelic groups between patients with NPM1-mutated AML and the normal population and we searched for an impact of the HLA-repertoire of the patient on survival outcomes.